Regional sites


09 Apr 2020 Insight Blog

Direct-To-Patient Limits Covid-19 Disruption

With the COVID-19 pandemic disrupting every facet of life, patients participating in a clinical trial have to deal with a whole new set of fears: not knowing if they will receive the medication on time (or at all), the risk of being exposed to the virus at traditional clinical trial centres, etc. For a long time — and to a certain extent, depending on the geographical region, still today — people were discouraged to go to hospitals to help prevent the spread of the virus.

Clinical trials themselves may also be affected by the crisis since hospitals may not be as capable of accommodating clinical trials during this demanding time. As a result, studies may have slowed down, been interrupted or even canceled due to pandemic.


Clinigen Clinical Supplies Management is committed to helping mitigate the risk of COVID-19 on clinical trials and is currently supporting over 40 studies linked to the prevention and treatment of the virus.

We are treating these projects with utmost urgency, and are happy to apply our expertise for the benefit of patients in these difficult times.


One of the ways Clinigen is helping clinical trial sponsors to limit COVID-19 related risks for their participants is through Direct-to-Patient clinical supply shipping. Through our specialty Direct-to-Patient logistics services, patients can remain compliant with their treatment schedule when they cannot, or do not want to, visit a traditional clinical trial site.

Our innovative Direct-to-Patient method is a patient-centric approach to clinical supplies in which the supplies are prepared, packaged, labelled, and then shipped directly to the patient's or caregiver's home. Our DtP logistics pre-planning ensures that products are delivered at the right time, at the right temperature, and within the right guidelines, even in these unprecedented times.

A traditional clinical trial can be turned into a DtP trial, either partly or completely. We have extensive experience in shipping the medication directly from the drug depot to the patient’s home, lessening the impact on sites such as hospitals that are under pressure from the current crisis. We also provide site to patient shipments, and can adapt your trial quickly, as needed.

With our agile global capabilities and expertise, we understand the needs of clinical trial sponsors and their patients, and can coordinate DtP trials and ensure their success.


We have over a decade of experience working together with many trial sponsors, couriers, and clinical sites managing Direct-to-Patient studies, and have delivered over 8,000 DtP shipments to trial participants.

With our traditional clinical supply services, shipping from depot to site, and DtP shipments from the depot to the patient’s home or the site to the patient’s home, we are perfectly positioned to ensure trial success even in these challenging times. Our expertise in depot to patient shipments enables us to ensure that patients receive their medication and remain healthy, with much less impact on the site. We are agile and can quickly adapt a trial to suit the needs of the trial sponsor, site and the patient.

How can we help your project?

Speak to a Clinical Supplies Management expert to discover how our Direct-to-Patient distribution can help you avoid clinical trial disruption and continue to make a difference in patients' lives.